Benefit finding in long-term prostate cancer survivors
Saved in:
| Title: | Benefit finding in long-term prostate cancer survivors |
|---|---|
| Authors: | Irène Lassmann, Andreas Dinkel, Birgitt Marten-Mittag, Matthias Jahnen, Helga Schulwitz, Jürgen E. Gschwend, Kathleen Herkommer |
| Source: | Support Care Cancer |
| Publisher Information: | Springer Science and Business Media LLC, 2021. |
| Publication Year: | 2021 |
| Subject Terms: | Male, 03 medical and health sciences, 0302 clinical medicine, Cancer Survivors, 4. Education, Quality of Life, Humans, Prostatic Neoplasms, Original Article, Cancer Survivors/psychology [MeSH], Cancer survivor, Aged [MeSH], Posttraumatic growth, Prostatic Neoplasms/mortality [MeSH], Humans [MeSH], Quality of Life/psychology [MeSH], Benefit finding, Male [MeSH], Prostatic Neoplasms/psychology [MeSH], Prostate cancer, Urological malignancy, ddc, Aged, 3. Good health |
| Description: | PurposeBenefit finding (BF) represents possible positive changes that people may experience after cancer diagnosis and treatment and has proven to be valuable to the psychological outcome. Knowledge of such beneficial consequences of prostate cancer (PCa) is limited in long-term survivors (> 5 years). Thus, the present study investigated the occurrence of benefit finding (BF) and its determinants in a large sample of (very-) long-term PCa survivors.MethodsBF was assessed in 4252 PCa survivors from the German database “Familial Prostate Cancer” using the German version of the Benefit Finding Scale (BFS). Associations between BF and sociodemographic, clinical, and psychosocial (e.g., depressive and anxiety symptoms and perceived severity of the disease experience) variables were analyzed using hierarchical multiple linear regression analysis.ResultsMean age at survey was 77.4 years (SD = 6.2) after a mean follow-up of 14.8 years (SD = 3.8). Mean BFS score was 3.14 (SD = 1.0); the prevalence of moderate-to-high BF (score ≥ 3) was 59.7%. Younger age at diagnosis, lower educational level, and higher perceived severity of the disease experience were predictive of BF. Objective disease severity or family history of PCa was not uniquely associated with BF.ConclusionsBF occurs in older, (very-) long-term PCa survivors. Our findings suggest that the self-asserted severity of the disease experience in a patient’s biography is linked to BF in the survivorship course above all tangible sociodemographic and clinical factors.Implications for cancer survivorsPCa survivors may express BF regardless of clinical disease severity. Treating urologists should consider inquiring BF to enrich a patient’s cancer narrative. |
| Document Type: | Article Other literature type |
| File Description: | application/pdf |
| Language: | English |
| ISSN: | 1433-7339 0941-4355 |
| DOI: | 10.1007/s00520-020-05971-3 |
| Access URL: | https://link.springer.com/content/pdf/10.1007/s00520-020-05971-3.pdf https://pubmed.ncbi.nlm.nih.gov/33447865 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236447 https://pubmed.ncbi.nlm.nih.gov/33447865/ https://www.scilit.net/article/c897e426fd1e8d58140f2c09af2809bb?action=show-references https://link.springer.com/article/10.1007/s00520-020-05971-3 https://link.springer.com/content/pdf/10.1007/s00520-020-05971-3.pdf https://repository.publisso.de/resource/frl:6446694 https://mediatum.ub.tum.de/doc/1637986/document.pdf |
| Rights: | CC BY |
| Accession Number: | edsair.doi.dedup.....6bd039caf55385d31267fd9024c5818f |
| Database: | OpenAIRE |
| Abstract: | PurposeBenefit finding (BF) represents possible positive changes that people may experience after cancer diagnosis and treatment and has proven to be valuable to the psychological outcome. Knowledge of such beneficial consequences of prostate cancer (PCa) is limited in long-term survivors (> 5 years). Thus, the present study investigated the occurrence of benefit finding (BF) and its determinants in a large sample of (very-) long-term PCa survivors.MethodsBF was assessed in 4252 PCa survivors from the German database “Familial Prostate Cancer” using the German version of the Benefit Finding Scale (BFS). Associations between BF and sociodemographic, clinical, and psychosocial (e.g., depressive and anxiety symptoms and perceived severity of the disease experience) variables were analyzed using hierarchical multiple linear regression analysis.ResultsMean age at survey was 77.4 years (SD = 6.2) after a mean follow-up of 14.8 years (SD = 3.8). Mean BFS score was 3.14 (SD = 1.0); the prevalence of moderate-to-high BF (score ≥ 3) was 59.7%. Younger age at diagnosis, lower educational level, and higher perceived severity of the disease experience were predictive of BF. Objective disease severity or family history of PCa was not uniquely associated with BF.ConclusionsBF occurs in older, (very-) long-term PCa survivors. Our findings suggest that the self-asserted severity of the disease experience in a patient’s biography is linked to BF in the survivorship course above all tangible sociodemographic and clinical factors.Implications for cancer survivorsPCa survivors may express BF regardless of clinical disease severity. Treating urologists should consider inquiring BF to enrich a patient’s cancer narrative. |
|---|---|
| ISSN: | 14337339 09414355 |
| DOI: | 10.1007/s00520-020-05971-3 |
Full Text Finder
Nájsť tento článok vo Web of Science